• DRAMP ID

    • DRAMP02842
    • Peptide Name

    • LfcinB(20-25)
    • Source

    • bovine
    • Family

    • bovine LfcinB
    • Gene

    • LTF
    • Sequence

    • RRWQWR
    • Sequence Length

    • 6
    • Protein Existence

    • Not found
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram+
    • Target Organism

      • [Ref.29984236] Gram-positive bacterium: Staphylococcus aureus ATCC 33591 (MIC=100 μg/ml; MBC=199 μg/ml)
    • Hemolytic Activity

      • [Ref.29984236] 3% hemolysis at 5 μM, 5% hemolysis at 12 μM, 5% hemolysis at 22 μM, 0% hemolysis at 50 μM, 2% hemolysis at 100 μM against human red blood cell.
      • [Ref.29551999] 7.1% hemolysis at 25μM, 50% hemolysis at >100μM against human red blood cells.
    • Cytotoxicity

      • Not included yet
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Not included yet
    • N-terminal Modification

    • Not included yet
    • C-terminal Modification

    • Not included yet
    • Nonterminal Modifications and Unusual Amino Acids

    • Not included yet
    • Stereochemistry

    • Not included yet
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP02842 helical wheel diagram
  • 1LFC-> 
    • Predicted Structure

    • There is no predicted structure for DRAMP02842.
    • Formula

    • C45H66N18O8
    • Absent Amino Acids

    • ACDEFGHIKLMNPSTVY
    • Common Amino Acids

    • R
    • Mass

    • 987.13
    • PI

    • 12.3
    • Basic Residues

    • 3
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 2
    • Net Charge

    • +3
    • Boman Index

    • -45.64
    • Hydrophobicity

    • -3.133
    • Aliphatic Index

    • 0
    • Half Life

      • Mammalian:1 hour
      • Yeast:2 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 11000
    • Absorbance 280nm

    • 2200
    • Polar Residues

    • 0

DRAMP02842

    • Function

    • Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.
  • ·Literature 1
    • Title

    • Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.
    • Reference

    • Biomed Res Int. 2018 Jun 10;2018:5252891
    • Author

    • Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Mart
  • ·Literature 2
    • Title

    • Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents against Clinically Relevant Gram-Positive and Gram-Negative Pathogens
    • Reference

    • Front Microbiol. 2018 Mar 2;9:329.
    • Author

    • Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SA, Vogel HJ
  • ·Literature 3
    • Title

    • Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs
    • Reference

    • PLoS One. 2010 Sep 10;5(9):e12684. doi: 10.1371/journal.pone.0012684
    • Author